Gavin T. Jones Buys 50,000 Shares of EKF Diagnostics Holdings plc (LON:EKF) Stock

EKF Diagnostics Holdings plc (LON:EKF) insider Gavin T. Jones acquired 50,000 shares of EKF Diagnostics stock in a transaction dated Tuesday, March 25th. The stock was purchased at an average cost of GBX 22 ($0.28) per share, for a total transaction of £11,000 ($14,241.33).

EKF Diagnostics Trading Down 3.6 %

LON EKF opened at GBX 21.20 ($0.27) on Friday. The firm has a market capitalization of £94.23 million, a price-to-earnings ratio of 19.73 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. EKF Diagnostics Holdings plc has a one year low of GBX 18.40 ($0.24) and a one year high of GBX 33.80 ($0.44). The company’s 50 day moving average price is GBX 23.14 and its 200 day moving average price is GBX 25.82.

EKF Diagnostics (LON:EKF) last issued its earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. On average, sell-side analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.